DK0549366T3 - Thiazolidinforbindelser indeholdende en quinolingruppe, deres fremstilling og deres terapeutiske anvendelser - Google Patents
Thiazolidinforbindelser indeholdende en quinolingruppe, deres fremstilling og deres terapeutiske anvendelserInfo
- Publication number
- DK0549366T3 DK0549366T3 DK92311814T DK92311814T DK0549366T3 DK 0549366 T3 DK0549366 T3 DK 0549366T3 DK 92311814 T DK92311814 T DK 92311814T DK 92311814 T DK92311814 T DK 92311814T DK 0549366 T3 DK0549366 T3 DK 0549366T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- compounds containing
- therapeutic uses
- quinoline group
- alkyl
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 title 1
- 150000003548 thiazolidines Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 230000003178 anti-diabetic effect Effects 0.000 abstract 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP34457091 | 1991-12-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0549366T3 true DK0549366T3 (da) | 1999-03-08 |
Family
ID=18370296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92311814T DK0549366T3 (da) | 1991-12-26 | 1992-12-24 | Thiazolidinforbindelser indeholdende en quinolingruppe, deres fremstilling og deres terapeutiske anvendelser |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5338855A (cs) |
| EP (1) | EP0549366B1 (cs) |
| JP (1) | JP2833948B2 (cs) |
| KR (1) | KR100198183B1 (cs) |
| CN (1) | CN1033639C (cs) |
| AT (1) | ATE165092T1 (cs) |
| AU (1) | AU654222B2 (cs) |
| CA (1) | CA2086179C (cs) |
| CZ (1) | CZ279917B6 (cs) |
| DE (1) | DE69225123T2 (cs) |
| DK (1) | DK0549366T3 (cs) |
| ES (1) | ES2115650T3 (cs) |
| FI (1) | FI925848A7 (cs) |
| GR (1) | GR3026656T3 (cs) |
| HU (1) | HU215448B (cs) |
| IL (1) | IL104237A (cs) |
| MX (1) | MX9207594A (cs) |
| NO (1) | NO302519B1 (cs) |
| NZ (1) | NZ245611A (cs) |
| RU (1) | RU2103265C1 (cs) |
| TW (1) | TW211008B (cs) |
| ZA (1) | ZA9210020B (cs) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO302471B1 (no) * | 1991-12-26 | 1998-03-09 | Sankyo Co | Tiazolidinforbindelser og farmasöytisk preparat |
| RU2114844C1 (ru) * | 1994-04-11 | 1998-07-10 | Санкио Компани Лимитед | Производные тиозолидиндиона или их фармацевтически приемлемые соли, фармацевтическая композиция на их основе и способ лечения или профилактики заболеваний |
| IL118474A (en) * | 1995-06-01 | 2001-08-08 | Sankyo Co | Benzimideol derivatives and pharmaceutical preparations containing them |
| US6147101A (en) * | 1995-06-02 | 2000-11-14 | Kyorin Pharmaceutical Co., Ltd. | N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same |
| JP3144624B2 (ja) * | 1995-06-02 | 2001-03-12 | 杏林製薬株式会社 | Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法 |
| US6001862A (en) * | 1995-06-02 | 1999-12-14 | Kyorin Pharameuticals Co., Ltd. | N-benzyldioxothiazolidylbenzamide derivatives and processes for preparing the same |
| EP0783888A1 (en) * | 1995-12-26 | 1997-07-16 | Sankyo Company Limited | Use of troglitazone and related thiazolidinediones in the manufacture of a medicament for the treatment and prophylaxis of osteoporosis |
| JPH10338679A (ja) * | 1997-04-08 | 1998-12-22 | Mitsubishi Rayon Co Ltd | チアゾリジン誘導体の製造方法 |
| US6414123B1 (en) * | 1997-10-21 | 2002-07-02 | Vitro Diagnostics, Inc. | Method for purifying FSH |
| US6077849A (en) * | 1998-04-02 | 2000-06-20 | Merck & Co., Inc. | Antidiabetic agents |
| US6028088A (en) * | 1998-10-30 | 2000-02-22 | The University Of Mississippi | Flavonoid derivatives |
| US6127394A (en) * | 1999-03-08 | 2000-10-03 | The University Of Mississippi | 1,2-Dithiolane derivatives |
| US6204288B1 (en) | 1999-03-08 | 2001-03-20 | The University Of Mississippi | 1,2-dithiolane derivatives |
| WO2001057007A1 (fr) * | 2000-02-01 | 2001-08-09 | Kyorin Pharmaceutical Co., Ltd. | Sel de metal alcalin de derive de thiazolidine-4,4-dione |
| US7888334B2 (en) | 2003-08-22 | 2011-02-15 | Antipodean Pharmaceuticals, Inc. | Mitoquinone derivatives used as mitochondrially targeted antioxidants |
| US7888335B2 (en) | 2003-08-22 | 2011-02-15 | Antipodean Pharmaceuticals, Inc. | Mitoquinone derivatives used as mitochondrially targeted antioxidants |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4725010A (en) * | 1986-07-18 | 1988-02-16 | Essex Group, Inc. | Control apparatus and method |
| JPS5522636A (en) * | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
| JPS6051189A (ja) * | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
| US5120754A (en) * | 1988-03-08 | 1992-06-09 | Pfizer Inc. | Thiazolidinedione hypoglycemic agents |
| US5130379A (en) * | 1988-03-08 | 1992-07-14 | Pfizer Inc. | Hypoglycemic thiazolidinedione derivatives |
| GB8910639D0 (en) * | 1989-05-09 | 1989-06-21 | Beecham Group Plc | Novel compounds |
| GB8919434D0 (en) * | 1989-08-25 | 1989-10-11 | Beecham Group Plc | Novel compounds |
| US5143930A (en) * | 1990-02-07 | 1992-09-01 | Sankyo Company, Limited | Thiazolidine derivatives with anti-diabetic activity, their preparation and their use |
| NO302471B1 (no) * | 1991-12-26 | 1998-03-09 | Sankyo Co | Tiazolidinforbindelser og farmasöytisk preparat |
-
1992
- 1992-12-22 NO NO924988A patent/NO302519B1/no not_active IP Right Cessation
- 1992-12-23 CA CA002086179A patent/CA2086179C/en not_active Expired - Fee Related
- 1992-12-23 HU HUP9204121A patent/HU215448B/hu not_active IP Right Cessation
- 1992-12-23 NZ NZ245611A patent/NZ245611A/en unknown
- 1992-12-23 FI FI925848A patent/FI925848A7/fi unknown
- 1992-12-23 ZA ZA9210020A patent/ZA9210020B/xx unknown
- 1992-12-24 TW TW081110380A patent/TW211008B/zh active
- 1992-12-24 AU AU30429/92A patent/AU654222B2/en not_active Ceased
- 1992-12-24 DK DK92311814T patent/DK0549366T3/da active
- 1992-12-24 KR KR1019920025528A patent/KR100198183B1/ko not_active Expired - Fee Related
- 1992-12-24 EP EP92311814A patent/EP0549366B1/en not_active Expired - Lifetime
- 1992-12-24 AT AT92311814T patent/ATE165092T1/de not_active IP Right Cessation
- 1992-12-24 ES ES92311814T patent/ES2115650T3/es not_active Expired - Lifetime
- 1992-12-24 DE DE69225123T patent/DE69225123T2/de not_active Expired - Fee Related
- 1992-12-25 JP JP4346121A patent/JP2833948B2/ja not_active Expired - Fee Related
- 1992-12-25 IL IL10423792A patent/IL104237A/en not_active IP Right Cessation
- 1992-12-25 RU RU92016230A patent/RU2103265C1/ru active
- 1992-12-26 CN CN92113835A patent/CN1033639C/zh not_active Expired - Fee Related
- 1992-12-28 CZ CS923896A patent/CZ279917B6/cs not_active IP Right Cessation
- 1992-12-28 US US07/997,210 patent/US5338855A/en not_active Expired - Fee Related
- 1992-12-28 MX MX9207594A patent/MX9207594A/es not_active IP Right Cessation
-
1998
- 1998-04-15 GR GR980400859T patent/GR3026656T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU9204121D0 (en) | 1993-04-28 |
| EP0549366B1 (en) | 1998-04-15 |
| CN1074679A (zh) | 1993-07-28 |
| US5338855A (en) | 1994-08-16 |
| IL104237A (en) | 1996-10-16 |
| NO302519B1 (no) | 1998-03-16 |
| CA2086179C (en) | 2000-10-17 |
| NO924988D0 (no) | 1992-12-22 |
| EP0549366A1 (en) | 1993-06-30 |
| ZA9210020B (en) | 1993-07-02 |
| ES2115650T3 (es) | 1998-07-01 |
| MX9207594A (es) | 1994-06-30 |
| JPH05255288A (ja) | 1993-10-05 |
| NZ245611A (en) | 1994-06-27 |
| TW211008B (cs) | 1993-08-11 |
| ATE165092T1 (de) | 1998-05-15 |
| HU215448B (hu) | 1999-04-28 |
| DE69225123D1 (de) | 1998-05-20 |
| HK1007050A1 (en) | 1999-03-26 |
| FI925848A7 (fi) | 1993-06-27 |
| CA2086179A1 (en) | 1993-06-27 |
| RU2103265C1 (ru) | 1998-01-27 |
| FI925848A0 (fi) | 1992-12-23 |
| HUT67704A (en) | 1995-04-28 |
| KR100198183B1 (ko) | 1999-06-15 |
| AU3042992A (en) | 1993-07-01 |
| CN1033639C (zh) | 1996-12-25 |
| DE69225123T2 (de) | 1998-12-24 |
| CZ279917B6 (cs) | 1995-08-16 |
| NO924988L (no) | 1993-06-28 |
| JP2833948B2 (ja) | 1998-12-09 |
| CZ389692A3 (en) | 1994-01-19 |
| GR3026656T3 (en) | 1998-07-31 |
| AU654222B2 (en) | 1994-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0549365T3 (da) | Thiazolidinforbindelser, deres fremstilling og deres terapeutiske anvendelser | |
| DK0549366T3 (da) | Thiazolidinforbindelser indeholdende en quinolingruppe, deres fremstilling og deres terapeutiske anvendelser | |
| DE68915308D1 (de) | 5-Lipoxygenasehemmende 4-(4-Phenyl-1-piperazinyl)phenole. | |
| DK39286A (da) | Imidazolderivater, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse derivater | |
| NO914192D0 (no) | 8-azabicyklo(3.2.1)oktylalkylthiazolidinon, fremgangsmaatefor fremstilling og anvendelse som medikamenter | |
| ATE98960T1 (de) | 1,8-benzonaphthyridinderivate, ihre herstellung und diese enthaltende zusammensetzungen. | |
| ES2044883T3 (es) | Procedimiento para preparar quinoxalinas sustituidas. | |
| DE3778088D1 (de) | Substituierte pyrimidochinoxaline. |